XBIO Xenetic Biosciences
- 3.8950
- -0.0754-1.90%
- 4.1299
- +0.2349+6.03%
Xenetic Biosciences News
8-K: Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
10-Q: Q2 2024 Earnings Report
25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
4: Statement of changes in beneficial ownership of securities-Officer PARSLOW JAMES F
8-K: Current report
8-K: Current report
8-K: Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)
Xenetic Biosciences | 8-K: Current report
Xenetic Biosciences | 10-K: FY2023 Annual Report
Xenetic Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dmitry Genkin(14.0%),CLS Therapeutics Ltd.(9.6%), etc.
Xenetic Biosciences | 8-K: Current report
Xenetic Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Mizrahy Moshe
Xenetic Biosciences | 3: Initial statement of beneficial ownership of securities-Director Mizrahy Moshe
Xenetic Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Lockshin Curtis
Xenetic Biosciences | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer PARSLOW JAMES F
Xenetic Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kornberg Roger D.
Xenetic Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Borisenko Grigory G.
Xenetic Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Dastoor Firdaus J.
Analysis
Price Target
No Data
No Data